Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
12/2004
12/01/2004EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004EP1481966A1 Novel arylamidine derivative or salt thereof
12/01/2004CN1551869A Novel compound
12/01/2004CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
11/2004
11/30/2004US6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
11/30/2004US6825191 Benzodiazepine derivatives
11/30/2004US6825189 Treating withdrawal symptoms caused by smoking cessation
11/25/2004US20040235870 Protein kinase inhibitors
11/25/2004DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/24/2004EP1478361A2 Arylsulfone derivatives
11/23/2004US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/18/2004WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004US20040229865 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
11/16/2004US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004US6818607 Bleach boosting components, compositions and laundry methods
11/11/2004WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004WO2004096134A2 Substituted 1,4-diazepines and uses thereof
11/11/2004WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004CA2523561A1 Substituted 1,4-diazepines and uses thereof
11/09/2004US6815543 Process for catalyzing the oxidation of organic compounds
11/04/2004US20040220401 Peptide mimetics, bioconvertable prodrug
11/04/2004US20040220237 Asthma and allergic inflammation modulators
11/04/2004US20040220222 Malonamide derivatives
11/04/2004US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004US20040220180 Compositions relating to novel compounds and targets thereof
11/04/2004US20040220179 controlling cell proliferation; antagonist of tumor suppression gene; autoimmune disease; Grave's disease; multiple sclerosis; antidiabetic agents; Addison's disease; antiarthritic agents; Crohn's disease
11/04/2004US20040220069 Bleach boosting components, compositions and laundry methods
11/03/2004CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
10/2004
10/28/2004WO2004092124A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
10/28/2004US20040213264 Service class and destination dominance traffic management
10/27/2004EP1244457B1 Use of modulators of annexin for the manufacture of a medicament for the treatment and/or prevention of arthritis and arthritic diseases
10/27/2004EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/26/2004US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
10/26/2004US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors
10/26/2004US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
10/21/2004WO2004089916A1 11-phenyl-dibenzodiazepine derivatives as rxr-antagonists
10/21/2004WO2004089313A2 Novel olanzapine forms and related methods of treatment
10/21/2004WO1995018619A9 Bicyclic fibrinogen antagonists
10/21/2004US20040209846 Heterocyclic analgesic compounds and methods of use thereof
10/21/2004CA2521337A1 11-phenyl-dibenzodiazepine derivatives as rxr-antagonists
10/20/2004EP1468689A1 2-methyl-thieno-benzodiazepine formulation
10/20/2004EP1468295A2 Water- soluble derivatives of lipophilic drugs
10/20/2004EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004EP1467988A1 Quinazoline(di)ones for invertebrate pest control
10/20/2004EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/20/2004CN1538848A Novel Benzo-fused heterocycles
10/19/2004US6806312 Thermoplastic resin composition
10/14/2004WO2004087711A1 Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents
10/14/2004US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders
10/13/2004EP1465879A2 Process for the preparation of tofisopam and new intermediates
10/13/2004EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/13/2004EP1185529B1 Pyrazolobenzodiazepines as cdk2 inhibitors
10/07/2004WO2004085410A1 Adenosine deaminase inhibitor and novel bacillus sp. iada-7 strain which produces it
10/07/2004WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/07/2004US20040198976 Method for synthesizing pyrazolobenzodiazepines
10/06/2004EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
10/06/2004CN1535266A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II
10/05/2004US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase
09/2004
09/29/2004EP1462445A1 Paraphenyldiamine derivatives concisting of a cyclic diaza group substituted by a cationic radical and use of these derivatives for dyeing keratin fibres
09/29/2004EP1462091A1 Composition for dyeing of keratinic fibers comprising a cationic derivative of p-phenylenediamine substituted by a diazacyclohexane or a diazacyloheptane
09/29/2004EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/29/2004EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity
09/29/2004EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
09/29/2004CN1533381A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
09/23/2004WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
09/23/2004US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/22/2004EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof
09/22/2004EP1000062B1 Tricyclic vasopressin agonists
09/22/2004CN1531531A Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders
09/21/2004US6794381 Succinoylamino lactams as inhibitors of aβ protein
09/16/2004WO2003096989A3 Anti tubercular drug: compositions and methods
09/16/2004DE10301923B3 Verfahren und Zwischenprodukte zur Herstellung von Olanzapin Processes and intermediates for the preparation of olanzapine
09/15/2004CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones
09/10/2004WO2004076424A1 Heterocyclic kinase inhibitors
09/09/2004US20040176358 Compositions and methods relating to novel compounds and targets thereof
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1234818B1 Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same
09/08/2004EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
09/08/2004CN1165525C Bleach builder components, compositions and laundry methods
09/02/2004WO2004074438A2 Ccr8 antagonists
09/02/2004WO2004073619A2 Ccr8 antagonists
09/02/2004WO2004056319A3 Substituted n-phenyl sulfonamide bradykinin antagonists
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/01/2004EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
09/01/2004EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
09/01/2004EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
09/01/2004CN1525171A Complex combinatorial chemical libraries encoded with tags
08/2004
08/31/2004US6784292 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof
08/31/2004US6784172 Acylation of 1,4-benzodiazepines, followed by nitrosation, reduction, imination with a cyclopentanone, cyclization, reduction and deacylation
08/26/2004WO2004058164A3 Asthma and allergic inflammation modulators
08/19/2004WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors
08/19/2004WO2004069197A2 Novel substituted 2,3-benzodiazepine derivatives
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004CA2512616A1 Novel substituted 2,3-benzodiazepine derivatives
08/18/2004EP1134220B1 Benzoxazole derivatives and drugs containing the same as the active ingredient
08/18/2004CN1522252A Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I
08/18/2004CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
08/18/2004CN1162432C 2,3-benzodiazepine derivatives
08/17/2004US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
08/17/2004US6777407 7bh-cyclopenta(b)(1,4)diazepino(6, 7, 1-hi)indole or a salt, useful for treatment of schizophrenia, obsessive compulsive disorder, depression, anxiety, panic disorder, obesity or epilepsy
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 60